These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8528105

  • 1. Quantitative and qualitative comparative analysis of gradient-separated hematopoietic cells from cord blood and chemotherapy-mobilized peripheral blood.
    Sato J, Kawano Y, Takaue Y, Hirao A, Makimoto A, Okamoto Y, Abe T, Shimokawa T, Iwai A, Kuroda Y.
    Stem Cells; 1995 Sep; 13(5):548-55. PubMed ID: 8528105
    [Abstract] [Full Text] [Related]

  • 2. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.
    Almici C, Carlo-Stella C, Mangoni L, Garau D, Cottafavi L, Ventura A, Armanetti M, Wagner JE, Rizzoli V.
    Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103
    [Abstract] [Full Text] [Related]

  • 3. Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood.
    Abe T, Ito M, Okamoto Y, Kim HJ, Takaue Y, Yasutomo K, Makimoto A, Yamaue T, Kawano Y, Watanabe T, Shimada T, Kuroda Y.
    Exp Hematol; 1997 Aug; 25(9):966-71. PubMed ID: 9257810
    [Abstract] [Full Text] [Related]

  • 4. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S, Kawano Y, Watanabe T, Nakagawa R, Suzuya H, Onishi T, Yamazaki J, Nakayama T, Kuroda Y, Takaue Y.
    Stem Cells; 2000 Aug; 18(3):190-5. PubMed ID: 10840072
    [Abstract] [Full Text] [Related]

  • 5. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A, Kawano Y, Takaue Y, Suzue T, Abe T, Sato J, Saito S, Okamoto Y, Makimoto A, Kawahito M.
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [Abstract] [Full Text] [Related]

  • 6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H.
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [Abstract] [Full Text] [Related]

  • 7. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR, Dejbakhsh-Jones S, Kusnierz-Glaz CR, Ginzton N, Still B, Negrin RS, Greenberg P, Strober S.
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [Abstract] [Full Text] [Related]

  • 8. CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.
    Georgiou GM, Roberton DM, Ellis WM, Shen BJ, Ekert H, Hosking CS.
    Clin Exp Immunol; 1983 Aug; 53(2):491-6. PubMed ID: 6309446
    [Abstract] [Full Text] [Related]

  • 9. Optimal processing of human umbilical cord blood for clinical banking.
    Denning-Kendall P, Donaldson C, Nicol A, Bradley B, Hows J.
    Exp Hematol; 1996 Oct; 24(12):1394-401. PubMed ID: 8913285
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 11. Is in vitro expansion of human cord blood cells clinically relevant?
    Denning-Kendall PA, Nicol A, Horsley H, Donaldson C, Bradley B, Hows JM.
    Bone Marrow Transplant; 1998 Feb; 21(3):225-32. PubMed ID: 9489644
    [Abstract] [Full Text] [Related]

  • 12. Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood.
    Yurasov SV, Flasshove M, Rafii S, Moore MA.
    Bone Marrow Transplant; 1996 Apr; 17(4):517-25. PubMed ID: 8722348
    [Abstract] [Full Text] [Related]

  • 13. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M.
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [Abstract] [Full Text] [Related]

  • 14. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 15. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
    Kwekkeboom J, Buurman DE, Ploemacher RE, Baars JW, Loos HA, Slaper-Cortenbach IC.
    Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
    [Abstract] [Full Text] [Related]

  • 16. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A, Xu G, Constantinescu D, Kashiwakura I, Farley T, Dobrila L, Rubinstein P, Adamson JW.
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [Abstract] [Full Text] [Related]

  • 17. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G, Callejas J, Sorg RV, Fischer J, Migliaccio AR, Wernet P.
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [Abstract] [Full Text] [Related]

  • 18. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
    de Wynter EA, Coutinho LH, Pei X, Marsh JC, Hows J, Luft T, Testa NG.
    Stem Cells; 1995 Sep; 13(5):524-32. PubMed ID: 8528102
    [Abstract] [Full Text] [Related]

  • 19. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
    Benboubker L, Domenech J, Linassier C, Desbois I, Delain M, Lamagnere JP, Colombat P, Binet C.
    Exp Hematol; 1995 Dec; 23(14):1568-73. PubMed ID: 8542948
    [Abstract] [Full Text] [Related]

  • 20. [Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].
    Ma Y, Zou P, Xiao J, Huang S.
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):330-3. PubMed ID: 11953192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.